Author

J. B. Ulmer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

H. Vahed· 4 shared L. BENMOHAMED· 4 shared L. Zayou· 4 shared N. R. Dhanushkodi· 4 shared A. Quadiri· 3 shared D. Gil· 3 shared S. Prakash· 3 shared A. B. Nesburn· 2 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

H. Vahed

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model

S. Prakash, N. R. Dhanushkodi, M. Singer, A. Quadiri, L. Zayou, H. Vahed, P.-G. Coulon, A. El Babsiri, D. Gil, J. B. Ulmer, L. BENMOHAMED

This paper develops a multi-antigen mRNA/LNP-based pan-CoV vaccine that provides cross-protective immunity against multiple SARS-CoV-2 variants in a hamster model.

bioRxiv · Feb 14, 2024 · PreprintImmunology

Cross-Protection Induced by Highly Conserved Human B, CD4+, and CD8+ T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern

S. F. Prakash, N. R. Dhanushkodi, L. Zayou, I. C. Ibraim, A. Quadiri, P. G. Coulon, D. F. Tifrea, B. Suzler, M. Amin, A. Chilukuri, R. A. Edwards, H. Vahed, A. B. Nesburn, B. D. Kuppermann, J. B. Ulmer, , L. BenMohamed

This paper describes a multi-epitope vaccine that provides cross-protection against multiple SARS-CoV-2 variants by inducing functional T cell responses.

Frontiers in Immunology · Jan 22, 2024Peer-reviewedImmunology

A Multi-Epitope/CXCL11 Prime/Pull Coronavirus Mucosal Vaccine Boosts the Frequency and the Function of Lung-Resident CD4+ and CD8+ Memory T Cells and Protects Against COVID-19-like Symptoms and Death Caused by SARS-CoV-2 infection

L. Zayou, S. Prakash, N. R. Dhanushkodi, A. Quadiri, I. C. Ibraim, M. Singer, A. Salem, A. M. Shaik, B. Suzer, A. Chilukuri, J. Tran, P. C. Nguyen, M. Sun, K. K. Hormi-Carver, A. Belmouden, , L. BENMOHAMED

Journal of Virology · Dec 21, 2023Peer-reviewedImmunology

High Frequencies of PD-1+TIM3+TIGIT+CTLA4+ Functionally Exhausted SARS-CoV-2-Specific CD4+ and CD8+ T Cells Associated with Severe Disease in Critically ill COVID-19 Patients

P.-G. A. Coulon, S. Prakash, N. R. Dhanushkodi, R. Srivastava, L. Zayou, D. F. Tifrea, R. A. Edwards, C. J. Figueroa, S. D. Schubl, L. Hsieh, A. B. Nesburn, B. D. Kuppermann, E. BAHRAOUI, H. Vahed, D. Gil, , L. BENMOHAMED

bioRxiv · Jan 30, 2022 · PreprintImmunology